Elad Gil
Co-Founder @ Color
San Francisco, United States
Elad Gil is a seed investor at Color in San Francisco focused on Software and Information Technology. Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
- Total investments:
- 259
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Elad Gil invests in
Stages Elad Gil invests in
Countries Elad Gil invests in
Round sizes
Round size
- Seed
- $2M–$17M
- Series A
- $9.5M–$50M
- Series B
- $27M–$117M
Investment Focus
Industry
- Software 82 (32%)
- Information Technology 33 (13%)
- Artificial Intelligence 33 (13%)
- SaaS 19 (7%)
- Internet 17 (7%)
Stage
- Seed 75 (29%)
- Series A 68 (26%)
- Series B 29 (11%)
- Series C 16 (6%)
- Funding Round 11 (4%)
Country
- United States 143 (55%)
- United Kingdom 4 (2%)
- Israel 2 (1%)
- Chile 1 (0%)
- Canada 1 (0%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Cognition is an applied artificial intelligence lab that focuses on reasoning and code. | $1B / Series D / May 27, 2026 | |
|
|
NavigateAI is an AI copilot for the physical world specifically designed for construction and field service teams to help them complete projects faster, with higher quality, and at lower costs. | $25M / Seed / May 26, 2026 | |
|
|
Socket is a new security company that can protect your most critical apps from supply chain attacks. We are taking an entirely new approach to one of the hardest problems in security in a stagnant part of the industry that has historically been obsessed with just reporting on known vulnerabilities.Socket is built by a team of open sourcemaintainers with over 1 billion monthly downloads. Everyone on the Socket team is an open source maintainer. We are all driven to defend the open source ecosystem from supply chain attacks and make it safe for everyone.Socket is unique because, unlike other tools, it detects and blocks supply chain attacks before they strike, mitigating the worst consequences. | $60M / Series C / May 20, 2026 | |
|
|
Frame Security is an AI‑driven cybersecurity company focused on human‑risk management and security‑awareness training. It helps organizations defend against AI‑powered social‑engineering attacks, phishing, and deepfakes by turning employees into an active line of defense rather than a passive vulnerability. | $50M / Venture - Series Unknown / May 11, 2026 | |
|
|
Petual is building the AI-powered platform for audit and compliance, transforming how enterprises manage SOX, operational, financial, and compliance risk. Our intelligent agents deliver precision, coverage, and speed impossible with manual testing. | $20M / Seed / Apr 23, 2026 | |
|
|
BuildForever build products that feel personal, magical and deeply human. | $9.5M / Seed / Apr 21, 2026 | |
|
|
Applied Compute is an AI startup that builds custom AI models and Specific Intelligence solutions for enterprises. | $80M / Venture - Series Unknown / Apr 08, 2026 | |
|
|
Saronic is building cutting-edge unmanned surface vehicles that enable maritime security and domain awareness by combining best-in-class hardware, software and artificial intelligence into one scalable, fully integrated platform. | $1.8B / Series D / Mar 31, 2026 | |
|
|
Crosby is a company with programmers from Ramp, Vanta, Meta, and Google joining attorneys. | $60M / Series B / Mar 31, 2026 | |
|
|
Harvey is an artificial intelligence technology service provider. | $200M / Series G / Mar 25, 2026 | |
| See all 259 investments → | |||
Co-Investors
About Color
Color is a population health technology company that focuses on providing large-scale health care programs and clinical testing. It improves the key health infrastructure systems to make health accessible, convenient, and cost-effective, serving health systems, employers, research institutions, and individual consumers.Its Population GenomicsPlatform offers modular and end-to-end solutions that enable organizations to effectively build and scale population health programs. It provides technology, software, and clinical services to help population programs launch and scale quickly. By combining innovative technology, specialized laboratory infrastructure, and clinical health services, Color creates complete and effective programs that include: Program strategy, planning, and implementation; Participant outreach and engagement; participant education and consent about testing and results; sample (blood or saliva) collection and genetic sequencing; data management and clinical reporting; HIPAA compliance and data security; return of results; clinical services, like genetic counseling and clinical pharmacy; personalized care routine; and ongoing population health management. Color’s partners include NorthShore University Health System, the National Institutes of Health (NIH), Ochsner Health System, Verily, Visa, Levi Strauss, and Salesforce.Elad Gil, Nish Bhat, Taylor Sittler, and Othman Laraki launched Color in 2015 and is based in Burlingame, California.
Color Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Claire Vo
Chief Product Officer
|
|||
|
Elad Gil
Co-founder
|
|||
|
Alicia Zhou
VP of Research and Scientific Affairs
|
|||
|
Caroline Savello
VP of Commercial
|
|||
|
Dror Berman
Investor (Seed round and on)
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Elad Gil invest in?
Elad Gil invests primarily in Software, Information Technology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 259 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Elad Gil's check size?
Elad Gil typically joins rounds of $2M–$17M at Seed, $9.5M–$50M at Series A and $27M–$117M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Elad Gil participates in.
When did Elad Gil last invest?
The most recent investment recorded for Elad Gil closed in May 2026. Shizune tracks 259 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!